IGFBP2 and lung carcinoma: Serum IGFBP-2 levels in patients with lung cancer were higher than that of benign lung disease (1,036.015, 766.304, 209.185–2,885.543 ng/ml), but the difference was not significant (P=0.148, Fig. 3A).